SCHEMBL6419293

SCHEMBL6419293

CC(=O)OC[C@H]1O[C@@H](n2nnc3c(N)ncnc32)[C@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.52
THRB P10828 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
HIF1A Q16665 1/20 0.52
ALDH1A1 P00352 2/20 0.49
TP53 P04637 1/20 0.49
MAPT P10636 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
PRKAB2 O43741 1/20 0.47
PRKAG1 P54619 1/20 0.47
PRKAA2 P54646 1/20 0.47
PRKAA1 Q13131 1/20 0.47
PRKAG3 Q9UGI9 1/20 0.47
PRKAG2 Q9UGJ0 1/20 0.47
PRKAB1 Q9Y478 1/20 0.47
DNMT1 P26358 1/20 0.47
DNMT3B Q9UBC3 1/20 0.47
CA1 P00915 11/20 0.46
CA2 P00918 11/20 0.46
CA9 Q16790 11/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8205660 0.83 ALDH1A1 (0.65) LMNASMN1; SMN2ALDH1A1TP53MAPT
SCHEMBL19889158 0.83 ALDH1A1 (0.65) LMNASMN1; SMN2ALDH1A1TP53MAPT
SCHEMBL31685764 0.83 ALDH1A1 (0.65) LMNASMN1; SMN2ALDH1A1TP53MAPT
SCHEMBL4425824 0.83 ALDH1A1 (0.65) LMNASMN1; SMN2ALDH1A1TP53MAPT
SCHEMBL11423681 0.83 ALDH1A1 (0.65) LMNASMN1; SMN2ALDH1A1TP53MAPT
SCHEMBL23982402 0.83 ALDH1A1 (0.65) LMNASMN1; SMN2ALDH1A1TP53MAPT
SCHEMBL13597931 0.83 ALDH1A1 (0.65) LMNASMN1; SMN2ALDH1A1TP53MAPT
SCHEMBL10033986 0.83 ALDH1A1 (0.65) LMNASMN1; SMN2ALDH1A1TP53MAPT
SCHEMBL22778927 0.82 ATG7 (0.55) LMNATHRBSMN1; SMN2HIF1AALDH1A1
SCHEMBL31685464 0.82 ALDH1A1 (0.54) LMNATHRBSMN1; SMN2HIF1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022127914-A1 NUCLEOSIDE-THIODIPHOSPHATE-HEPTOSE COMPOUNDS FOR TREATING CONDITIONS ASSOCIATED WITH ALPK1 ACTIVITY PYROTECH (BEIJING) BIOTECHNOLOGY CO., LTD. (CN) 2022-06-23 WO disclosed
EP-1589028-A2 Modified oligonucleotides, their preparation and their use Aventis Pharma Deutschland GmbH (DE) 2005-10-26 EP disclosed
EP-0680969-B1 Modified oligonucleotides, their preparation and their use AVENTIS PHARMA GMBH (DE) 2005-07-27 EP disclosed
US-6066720-A WITH AT LEAST ONE 8-AZAPURINE BASE; FORMS MORE STABLE HYBRIDIZATION COMPLEXES WITH NUCLEIC ACIDS; FOR ANTISENSE AGENTS, DIAGNOSTIC AGENTS, PROBES, PRIMERS HOECHST AKTIENGESELLSCHAFT (DE) 2000-05-23 US disclosed
EP-0680969-A2 Modified oligonucleotides, their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1995-11-08 EP disclosed